Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Atrovent, Atrovent HFA, Ipraxa, Apo-Ipratropium
Ipratropium bromide is an anticholinergic medication primarily used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the muscles in the airways, which allows them to open up and makes it easier to breathe. Ipratropium is generally considered a short-acting bronchodilator and belongs to the class of muscarinic antagonists.
For the treatment of bronchospasm associated with COPD, including chronic bronchitis and emphysema.
Outcome:
Increased anticholinergic effects (dry mouth, constipation, blurred vision)
Mechanism:
Additive anticholinergic effects
Outcome:
Hypokalemia
Mechanism:
Additive potassium loss
Outcome:
Slight increase in heart rate
Mechanism:
Additive effects on heart rate
Most likely new formulation: Combination therapy with newer bronchodilators (2025, 70% confidence)
Based on current usage trends and ongoing research, the likelihood of generic ipratropium remaining widely available is high (95%).
Anticholinergic, Bronchodilator
Quaternary Ammonium Compound